Atenolol

Generic Name
Atenolol
Brand Names
Tenoretic, Tenormin
Drug Type
Small Molecule
Chemical Formula
C14H22N2O3
CAS Number
29122-68-7
Unique Ingredient Identifier
50VV3VW0TI
Background

Atenolol is a cardioselective beta-blocker used in a variety of cardiovascular conditions.
...

Indication

Indicated for:

1) Management of hypertension alone and in combination with other antihypertensives.

2) Management of angina pectoris associated with coronary atherosclerosis.

3) Management of acute myocardial infarction in hemodynamically stable patients with a heart rate greater than 50 beats per minutes and a systolic blood pressure above 100 mmHg.
...

Associated Conditions
Alcohol Withdrawal Syndrome, Angina Pectoris, Atrial Fibrillation, Heart Failure, Hypertension, Migraine, Myocardial Infarction, Refractory Hypertension, Secondary prevention Myocardial infarction, Supra-ventricular Tachyarrhythmias, Thyrotoxicosis, Ventricular Tachyarrhythmias
Associated Therapies
-
Clinical Trials
Related News

The Confirmatory Olmesartan Plaque Regression Study

First Posted Date
2010-05-28
Last Posted Date
2018-12-24
Lead Sponsor
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Target Recruit Count
114
Registration Number
NCT01132768

An Active-controlled, Clinical Trial to Assess Central Hemodynamic Effects of Bisoprolol in Hypertensive Patients (Central Hemodynamic Assessment Measured in Patient With HypertensION [CHAMPION])

Phase 4
Completed
Conditions
Hypertension
Interventions
Drug: Bisoprolol
Drug: Atenolol
First Posted Date
2010-03-03
Last Posted Date
2014-02-13
Lead Sponsor
Merck KGaA, Darmstadt, Germany
Target Recruit Count
209
Registration Number
NCT01079962
Locations
🇰🇷

Severance Hosptial, 250, Seongsanno, Seodaemungu, Seoul, Korea, Republic of

Study of Atenolol Influence on Blood Pressure During Resistance Exercise

Phase 4
Completed
Conditions
Blood Pressure
Exercise
Interventions
Drug: atenolol
First Posted Date
2009-12-10
Last Posted Date
2009-12-15
Lead Sponsor
University of Sao Paulo
Target Recruit Count
10
Registration Number
NCT01030016
Locations
🇧🇷

University of São Paulo, São Paulo, Brazil

Effect of Ivabradine on Heart Rate & Effort Tolerance in Mitral Stenosis in Sinus Rhythm

Phase 3
Completed
Conditions
Mitral Stenosis
Interventions
Drug: Ivabradine
Drug: Atenolol
First Posted Date
2009-12-01
Last Posted Date
2011-07-07
Lead Sponsor
Govind Ballabh Pant Hospital
Target Recruit Count
50
Registration Number
NCT01022463
Locations
🇮🇳

G. B. Pant Hospital, New Delhi, Delhi, India

Examining Genetic Influence on Response to Beta-Blocker Medications in People With Type 2 Diabetes

Phase 4
Terminated
Conditions
Diabetes Mellitus, Type 2
Interventions
Drug: Atenolol
First Posted Date
2009-06-19
Last Posted Date
2019-09-26
Lead Sponsor
University of Maryland, Baltimore
Target Recruit Count
31
Registration Number
NCT00925119
Locations
🇺🇸

University of Maryland, Baltimore, Maryland, United States

Effects of Losartan Versus Atenolol on Aortic and Cardiac Muscle Stiffness in Adults With Marfan Syndrome

Phase 3
Completed
Conditions
Marfan Syndrome
Interventions
Drug: Losartan
Drug: Atenolol
First Posted Date
2008-07-29
Last Posted Date
2014-09-09
Lead Sponsor
Brigham and Women's Hospital
Target Recruit Count
40
Registration Number
NCT00723801
Locations
🇺🇸

Brigham and Women's Hospital, Boston, Massachusetts, United States

Effect of Carvedilol Controlled-Release (CR) and Atenolol on Central Blood Pressure

Phase 4
Completed
Conditions
Hypertension
Interventions
Drug: Carvedilol CR
Drug: Atenolol
First Posted Date
2008-04-30
Last Posted Date
2017-10-05
Lead Sponsor
University of Florida
Target Recruit Count
41
Registration Number
NCT00669279
Locations
🇺🇸

University of Florida, Gainesville, Florida, United States

Black Education and Treatment of Hypertension (BEAT HTN)

First Posted Date
2008-04-21
Last Posted Date
2012-12-04
Lead Sponsor
Creighton University
Target Recruit Count
99
Registration Number
NCT00661895
Locations
🇺🇸

Creighton Community Health Center, Omaha, Nebraska, United States

Multimodal Treatment Strategy for Cancer Cachexia

First Posted Date
2008-02-28
Last Posted Date
2016-02-12
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
15
Registration Number
NCT00625742
Locations
🇺🇸

UT MD Anderson Cancer Center, Houston, Texas, United States

Losartan Versus Atenolol for the Treatment of Marfan Syndrome

Phase 2
Completed
Conditions
Marfan Syndrome
Interventions
Drug: Losartan
Drug: Atenolol
First Posted Date
2008-01-15
Last Posted Date
2012-07-12
Lead Sponsor
University of British Columbia
Target Recruit Count
17
Registration Number
NCT00593710
Locations
🇨🇦

Children's Heart Centre, British Columbia's Children's Hospital, Vancouver, British Columbia, Canada

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy